Andere Sprachen China Medical System Holdings Limited

Aktien

A1JLYP

KYG211081248

867

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:08:24 06.06.2024			% 5 Tage	% 1. Jan.
7,21 ^HKD	0,00 %		+3,89 %	-47,90 %

09.05.	China Medical System Holdings Limited genehmigt Schlussdividende für das Jahr bis zum 31. Dezember 2023	CI
23.04.	China Medical System Holdings Limited gibt bekannt, dass der Antrag auf ein neues Medikament für Desidustat-Tabletten in China angenommen wurde	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

China Medical System Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023	09.05.
China Medical System: New Drug Application of Desidustat Tablets Accepted in China	23.04.
China Medical System's Anti-Anaemia NDA Accepted in China	23.04.
China Medical System Holdings Limited Announces New Drug Application of Desidustat Tablets Accepted in China	23.04.
Zydus Lifesciences' Desidustat Tablets Get Nod from China Regulator	23.04.
China Medical System Registers New Vitiligo Drug in Macau	17.04.
China Medical System Holdings Limited commences an Equity Buyback for 245,198,851 shares, representing 10% of its issued share capital, under the authorization approved on April 28, 2023.	02.04.
Incyte, China Medical System Sign Collaboration, License Agreement	01.04.
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia	01.04.
Incyte Corporation and China Medical System Holdings Limited Announce Collaboration and License Agreement for Povorcitinib, an Oral Jak1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia	01.04.
China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs	28.03.
China Medical System Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024	27.03.
China Medical System's Atopic Dermatitis Cream Gets Regulatory Nod for Phase 3 Trial	20.03.
China Medical System Holdings Limited Announces Approval to Conduct A Phase 3 Clinical Trial Investigating Ruxolitinib Cream in Atopic Dermatitis in China	19.03.
China Medical System Obtains Nod For Trials of Two Drugs	08.02.
China Medical System Holdings Limited Announces CMS-D001 Tablets and CMS-D002 Capsules Self-Developed	07.02.
China Medical Gains License to Sell Kidney Disease Drug Across China	05.02.
China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®	04.02.
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA	02.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen China Medical System Holdings Limited

Aktien

A1JLYP

KYG211081248

867

Andere Sprachen

Filter